Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
This article, published in Science, describes research to engineer a respiratory synctial virus (RSV) viral antigen that focuses on antigenic site ø, a metastable site specific to the prefusion state of the RSV fusion glycoprotein. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): McLellan JS, Chen M, Joyce MG, et al.
Visit web page (English)
(Located at www.sciencemag.org)
Citation: McLellan JS, Chen M, Joyce MG, et al. Structure-Based Design of a Fusion Glyoprotein Vaccines for Respiratory Syncytial Virus. Science. 2013;342(6158):592-598.